Literature DB >> 19484194

[New antiemetic strategies - not only in oncology].

K Jordan1, F Müller, H J Schmoll.   

Abstract

Nausea and vomiting are common symptoms in daily clinical practice. For appropriate diagnostics the knowledge of the pathopysiologic origin of nausea and vomiting is indispensable. Furthermore the diagnostic pathway usually has to be approached by an interdisciplinary team. Due to the broad spectrum of emetogenic causes several symptom-based treatment strategies are nowadays available. These include several kinds of antiemetics with different mechanisms of action and with an varying antiemetic potential. The antiemetic strategy is based on individual patient factors as well as on the receptor specific mechanism of action of the antiemetic drug and also the expected side effects. A number of modern antiemetic agents are available for the management of nausea and vomiting, including 5-HT(3)-receptor antagonists and NK(1) receptor antagonists. However, other conventional antiemetic drugs are still in use and should not be underestimated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19484194     DOI: 10.1007/s00108-009-2411-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  23 in total

1.  Thyroid function in hyperemesis gravidarum.

Authors:  N N Chan
Journal:  Lancet       Date:  1999-06-26       Impact factor: 79.321

2.  Tolerability of fosaprepitant and bioequivalency to aprepitant in healthy subjects.

Authors:  Kenneth C Lasseter; Jay Gambale; Bo Jin; Art Bergman; Marvin Constanzer; James Dru; Tae H Han; Anup Majumdar; Judith K Evans; M Gail Murphy
Journal:  J Clin Pharmacol       Date:  2007-05-24       Impact factor: 3.126

Review 3.  Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents.

Authors:  D Alhashimi; H Alhashimi; Z Fedorowicz
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

4.  A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines.

Authors:  B W Friedman; J Corbo; R B Lipton; P E Bijur; D Esses; C Solorzano; E J Gallagher
Journal:  Neurology       Date:  2005-02-08       Impact factor: 9.910

5.  The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.

Authors:  Paul J Hesketh; Steven M Grunberg; Richard J Gralla; David G Warr; Fausto Roila; Ronald de Wit; Sant P Chawla; Alexandra D Carides; Juliana Ianus; Mary E Elmer; Judith K Evans; Klaus Beck; Scott Reines; Kevin J Horgan
Journal:  J Clin Oncol       Date:  2003-10-14       Impact factor: 44.544

Review 6.  Domperidone: review of pharmacology and clinical applications in gastroenterology.

Authors:  Savio C Reddymasu; Irfan Soykan; Richard W McCallum
Journal:  Am J Gastroenterol       Date:  2007-05-03       Impact factor: 10.864

Review 7.  Use of antiemetic agents in acute gastroenteritis: a systematic review and meta-analysis.

Authors:  Lisa Ross DeCamp; Julie S Byerley; Nipa Doshi; Michael J Steiner
Journal:  Arch Pediatr Adolesc Med       Date:  2008-09

Review 8.  The area postrema and vomiting.

Authors:  A D Miller; R A Leslie
Journal:  Front Neuroendocrinol       Date:  1994-12       Impact factor: 8.606

9.  Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer.

Authors:  Manish Srivastava; Norman Brito-Dellan; Mellar P Davis; Marie Leach; Ruth Lagman
Journal:  J Pain Symptom Manage       Date:  2003-06       Impact factor: 3.612

10.  Progesterone and estrogen are potential mediators of gastric slow-wave dysrhythmias in nausea of pregnancy.

Authors:  J W Walsh; W L Hasler; C E Nugent; C Owyang
Journal:  Am J Physiol       Date:  1996-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.